FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593180930> ?p ?o ?g. }

• W2593180930 endingPage "01" @default.
• W2593180930 startingPage "P2" @default.
• W2593180930 abstract "Abstract Background Higher levels of the proliferation marker Ki67 at breast cancer (BC) diagnosis are increasingly recognised to indicate poorer prognosis. Change in ΔKi67 in response to endocrine treatment reflects response. The precise relationship between Ki67 and other clinico-path factors and how associations are affected by short exposure to aromatase inhibitor (AI) has been unclear. Methods POETIC was a UK-wide, phase III, randomised trial which tested perioperative use of AI (anastrozole (A), letrozole (L)) in postmenopausal women with early BC (Dowsett JNCI Monogr 2011). Ki67 was measured in a single central lab at diagnosis (B=baseline) and 2 weeks later at surgery (S) allowing in vivo assessment of AI sensitivity. POETIC recruited 4483 women from 130 UK centres. Paired biopsies were available for 96%. Relationship between Ki67 and clinico-path factors is described by summary statistics (median) and independent associations explored in multivariable linear regression models (MVM). Analyses of Ki67 at S and ΔKi67 (reduction) were adjusted for B Ki67 and surgical sample type. Results Absolute Ki67 (B) was associated with each classic prognostic factor. Factors affecting ΔKi67 in control pts were Ki67 (B), grade (B) and surgical sample type (core cut 4.1%; excision 17.7% p&lt;0.001). After 2 weeks of AI, variation in extent of ΔKi67 was dominated by PgR, HER2 and grade (B). Centres using L more often supplied excision samples (p&lt;0.001). In spite of this both surgical sample type and choice of AI (both p&lt;0.001) independently influenced ΔKi67 (core cut: A 65.1% L 73.8% excision A 75.2% L 81.3%). Pattern of change in grade between B and S differed for AI and control. Baseline Ki67 %Ki67 change (%) with 2 weeks AIVariableNMedianln(Ki67) P value (MVM)NMedianln (Ki67(S)/Ki67 (B)) P Value (MVM)All patients391315.2 252877.6 PgR (local) 0.01 &lt;0.001Positive221914.6 141180.0 Negative47720.4 32661.1 Not known121715.1 79177.0 HER2 (local) &lt;0.001 &lt;0.001Negative345914.3 224079.2 Positive40226.8 26552.9 Unknown5213.9 2385.5 Tumour grade (B) &lt;0.001 &lt;0.001G15489.1 34378.6 G2227514.5 149479.6 G370330.1 44762.1 Unknown38714.0 24475.4 Tumour size (S) 0.002 0.49&lt;2cm150312.9 98379.1 2-5cm222117.5 142576.4 &gt;5cm17416.9 11474.1 Histological type (B) &lt;0.001 0.58Ductal313816.3 203077.5 Lobular54911.9 35379.0 Other/Not known22613.1 14574.0 Nodes involved 0.03 0.530235714.1 153577.6 1-3110815.8 70878.2 4+43320.3 27876.1 Vascular invasion &lt;0.001 0.03Yes112119.9 71175.9 No260313.6 169578.2 Unknown18914.6 12275.8 Summary POETIC provides the largest multi-centre series of women in whom centrally assessed Ki67 has been correlated with classic clinico-path factors and impact of short term AI exposure explored. Choice of AI and surgical sample type are both dictated by participating site and their inter-relationship requires further review. Whether the greater suppression of Ki67 following L, a drug associated with better E2 suppression and aromatisation than A has clinical consequences is beyond the scope of this work. Relationships found (e.g. sample type, grade) are critical for interpretation of studies using Ki67 for prognosis and ΔKi67 as a pharmacodynamic response marker. Citation Format: Bliss JM, Morden J, Evans A, Holcombe C, Horgan K, Mallon E, Raghavan V, Skene A, Dodson A, Hills M, Detre S, Zabaglo L, Graf M, Banerji J, Gillman A, Robertson J, Dowsett M, Smith I, On Behalf of the POETIC Trialists. Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-01." @default.
• W2593180930 created "2017-03-16" @default.
• W2593180930 creator A5003319899 @default.
• W2593180930 creator A5006665510 @default.
• W2593180930 creator A5010879410 @default.
• W2593180930 creator A5019381008 @default.
• W2593180930 creator A5020035024 @default.
• W2593180930 creator A5023115832 @default.
• W2593180930 creator A5023779153 @default.
• W2593180930 creator A5030561107 @default.
• W2593180930 creator A5043736497 @default.
• W2593180930 creator A5052598759 @default.
• W2593180930 creator A5062531410 @default.
• W2593180930 creator A5064358450 @default.
• W2593180930 creator A5068020071 @default.
• W2593180930 creator A5075147710 @default.
• W2593180930 creator A5082993213 @default.
• W2593180930 creator A5085506605 @default.
• W2593180930 creator A5091075514 @default.
• W2593180930 creator A5091627649 @default.
• W2593180930 date "2017-02-15" @default.
• W2593180930 modified "2023-10-14" @default.
• W2593180930 title "Abstract P2-05-01: Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker" @default.
• W2593180930 doi "https://doi.org/10.1158/1538-7445.sabcs16-p2-05-01" @default.
• W2593180930 hasPublicationYear "2017" @default.
• W2593180930 type Work @default.
• W2593180930 sameAs 2593180930 @default.
• W2593180930 citedByCount "4" @default.
• W2593180930 countsByYear W25931809302017 @default.
• W2593180930 countsByYear W25931809302020 @default.
• W2593180930 countsByYear W25931809302023 @default.
• W2593180930 crossrefType "journal-article" @default.
• W2593180930 hasAuthorship W2593180930A5003319899 @default.
• W2593180930 hasAuthorship W2593180930A5006665510 @default.
• W2593180930 hasAuthorship W2593180930A5010879410 @default.
• W2593180930 hasAuthorship W2593180930A5019381008 @default.
• W2593180930 hasAuthorship W2593180930A5020035024 @default.
• W2593180930 hasAuthorship W2593180930A5023115832 @default.
• W2593180930 hasAuthorship W2593180930A5023779153 @default.
• W2593180930 hasAuthorship W2593180930A5030561107 @default.
• W2593180930 hasAuthorship W2593180930A5043736497 @default.
• W2593180930 hasAuthorship W2593180930A5052598759 @default.
• W2593180930 hasAuthorship W2593180930A5062531410 @default.
• W2593180930 hasAuthorship W2593180930A5064358450 @default.
• W2593180930 hasAuthorship W2593180930A5068020071 @default.
• W2593180930 hasAuthorship W2593180930A5075147710 @default.
• W2593180930 hasAuthorship W2593180930A5082993213 @default.
• W2593180930 hasAuthorship W2593180930A5085506605 @default.
• W2593180930 hasAuthorship W2593180930A5091075514 @default.
• W2593180930 hasAuthorship W2593180930A5091627649 @default.
• W2593180930 hasConcept C121608353 @default.
• W2593180930 hasConcept C126322002 @default.
• W2593180930 hasConcept C141071460 @default.
• W2593180930 hasConcept C143998085 @default.
• W2593180930 hasConcept C207886595 @default.
• W2593180930 hasConcept C2776166826 @default.
• W2593180930 hasConcept C2776215463 @default.
• W2593180930 hasConcept C2778504769 @default.
• W2593180930 hasConcept C29456083 @default.
• W2593180930 hasConcept C31174226 @default.
• W2593180930 hasConcept C530470458 @default.
• W2593180930 hasConcept C71924100 @default.
• W2593180930 hasConcept C90924648 @default.
• W2593180930 hasConceptScore W2593180930C121608353 @default.
• W2593180930 hasConceptScore W2593180930C126322002 @default.
• W2593180930 hasConceptScore W2593180930C141071460 @default.
• W2593180930 hasConceptScore W2593180930C143998085 @default.
• W2593180930 hasConceptScore W2593180930C207886595 @default.
• W2593180930 hasConceptScore W2593180930C2776166826 @default.
• W2593180930 hasConceptScore W2593180930C2776215463 @default.
• W2593180930 hasConceptScore W2593180930C2778504769 @default.
• W2593180930 hasConceptScore W2593180930C29456083 @default.
• W2593180930 hasConceptScore W2593180930C31174226 @default.
• W2593180930 hasConceptScore W2593180930C530470458 @default.
• W2593180930 hasConceptScore W2593180930C71924100 @default.
• W2593180930 hasConceptScore W2593180930C90924648 @default.
• W2593180930 hasIssue "4_Supplement" @default.
• W2593180930 hasLocation W25931809301 @default.
• W2593180930 hasOpenAccess W2593180930 @default.
• W2593180930 hasPrimaryLocation W25931809301 @default.
• W2593180930 hasRelatedWork W1985120806 @default.
• W2593180930 hasRelatedWork W2006377436 @default.
• W2593180930 hasRelatedWork W2007182497 @default.
• W2593180930 hasRelatedWork W2113053783 @default.
• W2593180930 hasRelatedWork W2119450372 @default.
• W2593180930 hasRelatedWork W2133675782 @default.
• W2593180930 hasRelatedWork W2144224845 @default.
• W2593180930 hasRelatedWork W2339773972 @default.
• W2593180930 hasRelatedWork W2410714427 @default.
• W2593180930 hasRelatedWork W2599190269 @default.
• W2593180930 hasVolume "77" @default.
• W2593180930 isParatext "false" @default.
• W2593180930 isRetracted "false" @default.
• W2593180930 magId "2593180930" @default.
• W2593180930 workType "article" @default.